Literature DB >> 8901607

Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue.

R Ziesche1, V Petkov, J Williams, S M Zakeri, W Mosgöller, M Knöfler, L H Block.   

Abstract

The combined effects of hypoxia and interleukin 1, lipopolysaccharide, or tumor necrosis factor alpha on the expression of genes encoding endothelial constitutive and inducible nitric oxide synthases, endothelin 1, interleukin 6, and interleukin 8 were investigated in human primary pulmonary endothelial cells and whole pulmonary artery organoid cultures. Hypoxia decreased the expression of constitutive endothelial nitric oxide synthase (NOS-3) mRNA and NOS-3 protein as compared with normoxic conditions. The inhibition of expression of NOS-3 corresponded with a reduced production of NO. A combination of hypoxia with bacterial lipopolysaccharide, interleukin 1 beta, or tumor necrosis factor alpha augmented both effects. In contrast, the combination of hypoxia and the inflammatory mediators superinduced the expression of endothelin 1, interleukin 6, and interleukin 8. Here, we have shown that inflammatory mediators aggravate the effect of hypoxia on the down-regulation of NOS-3 and increase the expression of proinflammatory cytokines in human pulmonary endothelial cells and whole pulmonary artery organoid cultures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901607      PMCID: PMC38017          DOI: 10.1073/pnas.93.22.12478

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells.

Authors:  M Yoshizumi; H Kurihara; T Morita; T Yamashita; Y Oh-hashi; T Sugiyama; F Takaku; M Yanagisawa; T Masaki; Y Yazaki
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

2.  Non-isotopic in situ detection of mRNA for interleukin-4 in archival human tissue.

Authors:  L Bromley; S P McCarthy; J E Stickland; C E Lewis; J O McGee
Journal:  J Immunol Methods       Date:  1994-01-03       Impact factor: 2.303

3.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

4.  Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.

Authors:  S Kourembanas; L P McQuillan; G K Leung; D V Faller
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia.

Authors:  L M Graham; A Vasil; M L Vasil; N F Voelkel; K R Stenmark
Journal:  Am Rev Respir Dis       Date:  1990-07

Review 6.  Nitric oxide: a physiologic messenger.

Authors:  C J Lowenstein; J L Dinerman; S H Snyder
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

7.  In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain.

Authors:  H Breitschopf; G Suchanek; R M Gould; D R Colman; H Lassmann
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Intimal proliferation in an organ culture of human internal mammary artery.

Authors:  C M Holt; S E Francis; S Rogers; P A Gadsdon; T Taylor; C Clelland; A Soyombo; A C Newby; G D Angelini
Journal:  Cardiovasc Res       Date:  1992-12       Impact factor: 10.787

9.  Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions.

Authors:  K L MacNaul; N I Hutchinson
Journal:  Biochem Biophys Res Commun       Date:  1993-11-15       Impact factor: 3.575

10.  Binding of human endothelium to Ulex europaeus I-coated Dynabeads: application to the isolation of microvascular endothelium.

Authors:  C J Jackson; P K Garbett; B Nissen; L Schrieber
Journal:  J Cell Sci       Date:  1990-06       Impact factor: 5.285

View more
  17 in total

Review 1.  Nitric oxide signaling in hypoxia.

Authors:  J J David Ho; H S Jeffrey Man; Philip A Marsden
Journal:  J Mol Med (Berl)       Date:  2012-02-18       Impact factor: 4.599

Review 2.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

3.  Ascites of severe acute pancreatitis in rats transcriptionally up-regulates expression of interleukin-6 and -8 in vascular endothelium and mononuclear leukocytes.

Authors:  A Masamune; T Shimosegawa; M Fujita; A Satoh; M Koizumi; T Toyota
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

4.  Amphotericin B severely affects expression and activity of the endothelial constitutive nitric oxide synthase involving altered mRNA stability.

Authors:  C V Suschek; E Bonmann; H Kleinert; M Wenzel; C Mahotka; H Kolb; U Förstermann; C D Gerharz; V Kolb-Bachofen
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

5.  Ethyl pyruvate inhibits hypoxic pulmonary vasoconstriction and attenuates pulmonary artery cytokine expression.

Authors:  Ben M Tsai; Tim Lahm; Eric D Morrell; Paul R Crisostomo; Jeffrey Poynter; Meijing Wang; Daniel R Meldrum
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

6.  C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats.

Authors:  W Weidebach; V S T Viana; E P Leon; C Bueno; A S Leme; F M Arantes-Costa; M A Martins; P H N Saldiva; E Bonfa
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

7.  Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis.

Authors:  Neeraj Dhaun; Pajaree Lilitkarntakul; Iain M Macintyre; Eline Muilwijk; Neil R Johnston; David C Kluth; David J Webb; Jane Goddard
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-11

8.  Active stabilization of human endothelial nitric oxide synthase mRNA by hnRNP E1 protects against antisense RNA and microRNAs.

Authors:  J J David Ho; G Brett Robb; Sharon C Tai; Paul J Turgeon; Imtiaz A Mawji; H S Jeffrey Man; Philip A Marsden
Journal:  Mol Cell Biol       Date:  2013-03-11       Impact factor: 4.272

9.  Loss of endothelial nitric oxide synthase exacerbates intestinal and lung injury in experimental necrotizing enterocolitis.

Authors:  Natalie A Drucker; Amanda R Jensen; Jan P Te Winkel; Michael J Ferkowicz; Troy A Markel
Journal:  J Pediatr Surg       Date:  2018-03-08       Impact factor: 2.545

10.  Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Authors:  O Hernández-Perera; D Pérez-Sala; J Navarro-Antolín; R Sánchez-Pascuala; G Hernández; C Díaz; S Lamas
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.